| # | Drug | Count |
|---|---|---|
| 0 | EVOLOCUMAB | 2523 |
| 1 | DENOSUMAB | 1212 |
| 2 | ERENUMAB-AOOE | 1024 |
| 3 | ETANERCEPT | 687 |
| 4 | DARBEPOETIN ALFA | 386 |
| 5 | PEGFILGRASTIM | 356 |
| 6 | LEUPROLIDE ACETATE | 346 |
| 7 | EPOETIN ALFA | 283 |
| 8 | ROMOSOZUMAB-AQQG | 115 |
| 9 | CARFILZOMIB | 102 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIFLUFOLASTAT F-18 | 26 | 0.0778 |
| 1 | TRASTUZUMAB-ANNS | 89 | 0.0588 |
| 2 | ANTICOAGULANT SODIUM CITRATE SOLUTION | 1 | 0.0476 |
| 3 | ADALIMUMAB-ATTO | 75 | 0.0466 |
| 4 | INFLIXIMAB-AXXQ | 41 | 0.0353 |
| 5 | PEGFILGRASTIM | 356 | 0.0297 |
| 6 | AFLIBERCEPT-AYYH | 3 | 0.0297 |
| 7 | RUBIDIUM CHLORIDE RB-82 | 3 | 0.0259 |
| 8 | EPOETIN ALFA | 283 | 0.0239 |
| 9 | AVACINCAPTAD PEGOL | 8 | 0.0227 |
| # | Drug class | Count |
|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 2523 |
| 1 | RANK Ligand Inhibitor [EPC] | 1212 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 821 |
| 3 | Leukocyte Growth Factor [EPC] | 432 |
| 4 | Erythropoiesis-stimulating Agent [EPC] | 386 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 108 |
| 6 | Proteasome Inhibitor [EPC] | 105 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 99 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 92 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 59 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 2523 | 0.0980 |
| 1 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 2 | Radioactive Diagnostic Agent [EPC] | 26 | 0.0083 |
| 3 | Erythropoiesis-stimulating Agent [EPC] | 386 | 0.0071 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 99 | 0.0065 |
| 5 | RANK Ligand Inhibitor [EPC] | 1212 | 0.0059 |
| 6 | Uric Acid-specific Enzyme [EPC] | 18 | 0.0046 |
| 7 | Leukocyte Growth Factor [EPC] | 432 | 0.0030 |
| 8 | Endoglycosidase [EPC] | 5 | 0.0027 |
| 9 | Interferon gamma [EPC] | 3 | 0.0021 |